Anika Therapeutics, Inc. (ANIK) › Net IncomeAnika Therapeutics, Inc. (ANIK) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: $3.69M2010: $4.32M2011: $8.47M2012: $11.76M2013: $20.57M2014: $38.32M2015: $30.76M2016: $32.55M2017: $31.82M2018: $18.72M2019: $27.19M2020: -$23.98M2021: $4.13M2022: -$14.86M2023: -$82.67M2024: -$56.38M2025: -$10.88M-$10.88M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$10.88M+80.7%2024-$56.38M+31.8%2023-$82.67M-456.3%2022-$14.86M-459.4%2021$4.13M+117.2%2020-$23.98M-188.2%2019$27.19M+45.2%2018$18.72M-41.2%2017$31.82M-2.2%2016$32.55M+5.8%2015$30.76M-19.7%2014$38.32M+86.2%2013$20.57M+75.0%2012$11.76M+38.9%2011$8.47M+96.2%2010$4.32M+17.0%2009$3.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share